+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Human papillomavirus type 16 viral load in relation to HIV infection, cervical neoplasia and cancer in Senegal



Human papillomavirus type 16 viral load in relation to HIV infection, cervical neoplasia and cancer in Senegal



Cancer Epidemiology 38(4): 369-375



The importance of human papillomavirus (HPV) viral load in the pathogenesis of cervical cancer among HIV-infected and HIV-uninfected women has not yet been established. In this cross-sectional study, HPV-16 viral loads were measured using previously-collected and frozen cervical swab samples from 498 HPV-16 positive Senegalese women (368 HIV-seronegative, 126 HIV-1 and/or HIV-2 seropositive). The real-time polymerase chain reaction assay was used to quantify HPV-16 E7 copy number normalized by human cellular DNA (β-actin), and viral loads were log10 transformed. Associations between HPV-16 viral load, degree of cervical abnormality, and HIV status were assessed using multinomial and linear regression methods. Compared to women with normal cytology, the likelihood of CIN1 (ORa: 1.21, 95% CI 0.93-1.57), CIN2-3 (ORa: 2.38, 95% CI 1.72-3.29) and cancer (ORa: 2.12, 95% CI 1.52-2.96) was found to increase for each 1-unit log10 increase in HPV-16 viral load. Compared to HIV-negative women, HIV-positive women had higher average HPV-16 viral load values (βa: 0.39, 95% CI 0.03-0.75), even after accounting for degree of cervical abnormality. In our study of women including those with cancer, HPV-16 viral load was associated with a higher likelihood of cervical abnormalities. However, substantial overlaps across categories of disease severity existed. Higher viral load among HIV-infected individuals may indicate that HIV infection influences HPV viral replication factors.

(PDF emailed within 0-6 h: $19.90)

Accession: 053612054

Download citation: RISBibTeXText

PMID: 24852136

DOI: 10.1016/j.canep.2014.04.005


Related references

Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia. Journal of Infectious Diseases 194(12): 1706-1712, 2006

Variation in human papillomavirus type-16 viral load within different histological grades of cervical neoplasia. Journal of Medical Virology 79(9): 1366-1369, 2007

High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer. International Journal of Cancer 124(2): 381-386, 2009

Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18. International Journal of Cancer 140(8): 1747-1756, 2017

Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. Cancer Letters 170(1): 19-24, September 10, 2001

Viral load of human papillomavirus and high-grade cervical intraepithelial neoplasia. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 95(1): 56-57, 2006

Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer. Cancer Epidemiology, Biomarkers & Prevention 14(5): 1311-1314, 2005

T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection. Journal of General Virology 77: 2183-2191, 1996

Serial measurement of type-specific human papillomavirus load enables classification of cervical intraepithelial neoplasia lesions according to occurring human papillomavirus-induced pathway. European Journal of Cancer Prevention 26(2): 156-164, 2016

Human papillomavirus prevalence, viral load and cervical intraepithelial neoplasia in HIV-infected women. Brazilian Journal of Infectious Diseases 6(3): 129-135, 2002

Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study. International Journal of Cancer 68(6): 731-738, 1996

Human papillomavirus viral load in cervical intraepithelial neoplasia as a prognostic factor in a Mexican population. Genetics and Molecular Research 11(4): 4720-4727, 2013

Association between human papillomavirus DNA load and development of cervical intraepithelial neoplasia and cervical cancer. International Journal of Gynecological Cancer 18(4): 755-760, 2007

Viral infection, human papillomavirus DNA, and cervical neoplasia. British Medical Journal 296(6624): 789, 1988

Viral infection, human papillomavirus DNA, and cervical neoplasia. British Medical Journal 296(6629): 1127, 1988